Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Rasa3 deficiency minimally affects thrombopoiesis but promotes severe thrombocytopenia due to integrin-dependent platelet clearance
Robert H. Lee, … , Anita Eckly, Wolfgang Bergmeier
Robert H. Lee, … , Anita Eckly, Wolfgang Bergmeier
Published March 15, 2022
Citation Information: JCI Insight. 2022;7(8):e155676. https://doi.org/10.1172/jci.insight.155676.
View: Text | PDF
Research Article Cell biology Hematology

Rasa3 deficiency minimally affects thrombopoiesis but promotes severe thrombocytopenia due to integrin-dependent platelet clearance

  • Text
  • PDF
Abstract

Platelet homeostasis is dependent on a tight regulation of both platelet production and clearance. The small GTPase Rap1 mediates platelet adhesion and hemostatic plug formation. However, Rap1 signaling is also critical for platelet homeostasis as both Rap1 deficiency and uninhibited Rap1 signaling lead to marked thrombocytopenia in mice. Here, we investigated the mechanism by which deficiency in Rasa3, a critical negative regulator of Rap1, causes macrothrombocytopenia in mice. Despite marked morphological and ultrastructural abnormalities, megakaryocytes in hypomorphic Rasa3hlb/hlb (R3hlb/hlb) or Rasa3–/– mice demonstrated robust proplatelet formation in vivo, suggesting that defective thrombopoiesis is not the main cause of thrombocytopenia. Rather, we observed that R3hlb/hlb platelets became trapped in the spleen marginal zone/red pulp interface, with evidence of platelet phagocytosis by macrophages. Clearance of mutant platelets was also observed in the liver, especially in splenectomized mice. Platelet count and platelet life span in Rasa3-mutant mice were restored by genetic or pharmacological approaches to inhibit the Rap1/talin1/αIIbβ3 integrin axis. A similar pattern of splenic clearance was observed in mice injected with anti-αIIbβ3 but not anti–glycoprotein Ibα platelet-depleting antibodies. In summary, we describe a potentially novel, integrin-based mechanism of platelet clearance that could be critical for our understanding of select inherited and acquired thrombocytopenias.

Authors

Robert H. Lee, Dorsaf Ghalloussi, Gabriel L. Harousseau, Joseph P. Kenny, Patrick A. Kramer, Fabienne Proamer, Bernhard Nieswandt, Matthew J. Flick, Christian Gachet, Caterina Casari, Anita Eckly, Wolfgang Bergmeier

×

Figure 2

PPF by R3hlb/hlb MKs is impaired ex vivo but normal in vivo.

Options: View larger image (or click on image) Download as PowerPoint
PPF by R3hlb/hlb MKs is impaired ex vivo but normal in vivo.
(A) Represe...
(A) Representative images of ex vivo proplatelet-forming MKs from R3+/+ (upper panels) and R3hlb/hlb mice (lower panels) taken at the indicated time points after start of imaging. Samples were stained with anti–GPIX-AF488 to label MKs/platelets (green). Scale bars: 10 μm. Yellow lines delimit BM pieces. (B) MKs released from BM explants, expressed as number of MKs released per explant in each field of view (n = 9–11). (C) Proplatelet-forming MKs in BM explants from R3+/+ and R3hlb/hlb mice, expressed as percentage of total MKs per field of view (n = 12). (D) Representative images of in vitro proplatelet-forming MKs from R3+/+ (top) and R3hlb/hlb (bottom) mice. Scale bars: 50 μm. Red asterisk marks the MK cell body. (E) Percentage of proplatelet-forming MKs from R3+/+ and R3hlb/hlb mice in vitro (n = 6–7). (F and G) Quantification of the proplatelet (PP) diameter (μm) (n = 50 MKs) and number of PP tips per MK (n = 20–24). (H) Representative still frames from calvarial BM 2P-IVM videos showing PPF in R3+/+, R3hlb/hlb, and R3–/– Cdg1+/– mice. Vessels were visualized by i.v. administration of tetramethylrhodamine-dextran (red), and MKs/platelets were labeled with anti–GPIX-AF488 antibodies (green). Scale bars: 50 μm. Blue arrows point to PP extensions within blood vessels. (I) Quantification of in vivo PPF by MKs in BM of R3+/+, R3hlb/hlb, and R3–/– Cdg1+/– mice expressed as percentage of total MKs per field of view (n = 5–6 mice). Data shown as mean ± SEM. Statistical significance was determined using unpaired 2-tailed Student’s t test in B, C, and E–G or 1-way ANOVA in I.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts